The psychometric properties of the Leicester Cough Questionnaire and Respiratory Symptoms in CF tool in cystic fibrosis : A preliminary study
Copyright © 2016 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved..
BACKGROUND: There are few tools to quantify the impact of cough in cystic fibrosis (CF). The psychometric properties of the Leicester Cough Questionnaire (LCQ) and Respiratory Symptoms in CF (ReS-CF) tool were investigated in adults with CF.
METHODS: Validity and reliability were assessed in clinically stable participants who completed the questionnaires twice, along with the Cystic Fibrosis Questionnaire - Revised (CFQ-R). Responsiveness was assessed by change in questionnaires following treatment for an acute respiratory exacerbation.
RESULTS: Correlations between the LCQ and CFQ-R respiratory domain were moderate (n=59, rs=0.78, p<0.001). Correlations between ReS-CF and CFQ-R respiratory domain were fair (rs=-0.50, p<0.001). The LCQ total score was repeatable (ICC 0.92, 95%CI 0.87-0.96, n=50). In those reporting improvement in symptoms following treatment (n=36), LCQ total score had a mean change of 4.6 (SD 3.7) and effect size of 1.2.
CONCLUSIONS: The LCQ and ReS-CF appear to be valid, reliable and responsive in CF.
TRIAL REGISTRATION: www.anzctr.org.au: ACTRN12615000262505.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2017 |
|---|---|
| Erschienen: |
2017 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
|---|---|
| Enthalten in: |
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society - 16(2017), 3 vom: 15. Mai, Seite 425-432 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ward, Nathan [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Cough |
|---|
| Anmerkungen: |
Date Completed 12.03.2018 Date Revised 12.03.2018 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jcf.2016.11.011 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM267216211 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM267216211 | ||
| 003 | DE-627 | ||
| 005 | 20231224220207.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jcf.2016.11.011 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0890.xml |
| 035 | |a (DE-627)NLM267216211 | ||
| 035 | |a (NLM)27986494 | ||
| 035 | |a (PII)S1569-1993(16)30669-5 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ward, Nathan |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The psychometric properties of the Leicester Cough Questionnaire and Respiratory Symptoms in CF tool in cystic fibrosis |b A preliminary study |
| 264 | 1 | |c 2017 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 12.03.2018 | ||
| 500 | |a Date Revised 12.03.2018 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2016 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved. | ||
| 520 | |a BACKGROUND: There are few tools to quantify the impact of cough in cystic fibrosis (CF). The psychometric properties of the Leicester Cough Questionnaire (LCQ) and Respiratory Symptoms in CF (ReS-CF) tool were investigated in adults with CF | ||
| 520 | |a METHODS: Validity and reliability were assessed in clinically stable participants who completed the questionnaires twice, along with the Cystic Fibrosis Questionnaire - Revised (CFQ-R). Responsiveness was assessed by change in questionnaires following treatment for an acute respiratory exacerbation | ||
| 520 | |a RESULTS: Correlations between the LCQ and CFQ-R respiratory domain were moderate (n=59, rs=0.78, p<0.001). Correlations between ReS-CF and CFQ-R respiratory domain were fair (rs=-0.50, p<0.001). The LCQ total score was repeatable (ICC 0.92, 95%CI 0.87-0.96, n=50). In those reporting improvement in symptoms following treatment (n=36), LCQ total score had a mean change of 4.6 (SD 3.7) and effect size of 1.2 | ||
| 520 | |a CONCLUSIONS: The LCQ and ReS-CF appear to be valid, reliable and responsive in CF | ||
| 520 | |a TRIAL REGISTRATION: www.anzctr.org.au: ACTRN12615000262505 | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Cough | |
| 650 | 4 | |a Cystic fibrosis | |
| 650 | 4 | |a Leicester Cough Questionnaire | |
| 650 | 4 | |a Signs and symptoms, respiratory | |
| 650 | 4 | |a Surveys and questionnaires | |
| 700 | 1 | |a Stiller, Kathy |e verfasserin |4 aut | |
| 700 | 1 | |a Rowe, Hilary |e verfasserin |4 aut | |
| 700 | 1 | |a Holland, Anne E |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society |d 2002 |g 16(2017), 3 vom: 15. Mai, Seite 425-432 |w (DE-627)NLM15136754X |x 1873-5010 |7 nnns |
| 773 | 1 | 8 | |g volume:16 |g year:2017 |g number:3 |g day:15 |g month:05 |g pages:425-432 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jcf.2016.11.011 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 16 |j 2017 |e 3 |b 15 |c 05 |h 425-432 | ||